Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Askanase · SciRah

Researcher profile · Semantic Scholar

A. Askanase

Share profile

A. Askanase — researcher profile on SciRah

h-index: 43
Works: 275
Citations: 8,236

Most-cited papers

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
L. Sammaritano, A. Askanase, B. Bermas, M. Dall'Era +48 more
2025Arthritis & Rheumatology99 citations
Semantic Scholar
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
L. Sammaritano, A. Askanase, B. Bermas, M. Dall'Era +48 more
2025Arthritis care & research86 citations
Semantic Scholar
Machine Learning Identifies Clusters of Longitudinal Autoantibody Profiles Predictive of Systemic Lupus Erythematosus Disease Outcomes
May Y. Choi, Irene Y. Chen, A. Clarke, M. Fritzler +37 more
2023Annals of the Rheumatic Diseases77 citations Open access
Semantic Scholar
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
Ronald F. van Vollenhoven, A. Askanase, A. Bomback, I. Bruce +9 more
2022Lupus Science and Medicine59 citations Open access
Semantic Scholar
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
M. Ugarte-Gil, J. Hanly, M. Urowitz, C. Gordon +31 more
2022Annals of the Rheumatic Diseases57 citations Open access
Semantic Scholar
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of Obexelimab in Systemic Lupus Erythematosus with Exploration of Response Based on Gene Pathway Co-Expression Patterns.
J. Merrill, J. Guthridge, Miles Smith, J. June +15 more
2023Arthritis & Rheumatology54 citations
Semantic Scholar
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials.
I. Parodis, J. Lindblom, R. A. Levy, M. Zen +10 more
2024The Lancet Rheumatology33 citations Open access
Semantic Scholar
Association between severe non-adherence to hydroxychloroquine and SLE flares, damage, and mortality in 660 patients from the SLICC Inception Cohort
Y. Nguyen, B. Blanchet, M. Urowitz, J. Hanly +34 more
2023Arthritis & Rheumatology26 citations Open access
Semantic Scholar
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce
K. Connelly, Laura E. Eades, R. Koelmeyer, D. Ayton +24 more
2023Nature Reviews Rheumatology25 citations Open access
Semantic Scholar
New and future therapies: Changes in the therapeutic armamentarium for SLE.
A. Askanase, L. Khalili, Wei Tang, P. Mertz +5 more
2023Baillière's Best Practice & Research : Clinical Rheumatology24 citations Open access
Semantic Scholar
The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis.
Despina Michailidou, Y. Gartshteyn, A. Askanase, Andras Perl
2025Autoimmunity Reviews22 citations
Semantic Scholar
Longitudinal Analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
May Y. Choi, A. Clarke, M. Urowitz, J. Hanly +34 more
2022Annals of the Rheumatic Diseases21 citations Open access
Semantic Scholar
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
C. Almeida-Brasil, J. Hanly, M. Urowitz, A. Clarke +35 more
2022Lupus Science and Medicine17 citations Open access
Semantic Scholar
SLAMF6 compartmentalization enhances T cell functions
Y. Gartshteyn, A. Askanase, R. Song, Shoiab Bukhari +3 more
2022Life Science Alliance17 citations Open access
Semantic Scholar
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
A. Askanase, D. D'Cruz, Kenneth Kalunian, Joan T. Merrill +7 more
2024The Lancet Rheumatology16 citations
Semantic Scholar
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations
A. Askanase, R. Furie, M. Dall'Era, A. Bomback +10 more
2024Lupus Science and Medicine16 citations Open access
Semantic Scholar
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus
G. Bertsias, A. Askanase, A. Doria, Amit Saxena +1 more
2024Rheumatology15 citations
Semantic Scholar
The Impact of Telemedicine on Rheumatology Care
Wei Tang, Sean Inzerillo, J. Weiner, L. Khalili +6 more
2022Frontiers in Medicine14 citations Open access
Semantic Scholar
Improving resource utilisation in SLE drug development through innovative trial design
S. Garces, E. Karis, J. Merrill, A. Askanase +3 more
2023Lupus Science and Medicine13 citations Open access
Semantic Scholar
A Phase 1 Study of NKX019, an Allogeneic Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy in Patients with Systemic Lupus Erythematosus
A. Askanase, L. Khalili, Cornell Chang, Alison Blaus +3 more
2024Blood12 citations
Semantic Scholar
Inflammatory and thrombotic valvulopathies in autoimmune disease
Y. Gartshteyn, N. Bhave, M. Joseph, A. Askanase +1 more
2022Heart12 citations
Semantic Scholar
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
Joan T. Merrill, J. Guthridge, Miles Smith, J. June +15 more
202310 citations
Semantic Scholar
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
F. Cardwell, S. Elliott, Ricky Chin, Y. St. Pierre +29 more
2022Lupus Science and Medicine10 citations Open access
Semantic Scholar
Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients
Brendan Denvir, Philip M. Carlucci, K. Corbitt, J. Buyon +14 more
2024Frontiers in Epidemiology9 citations Open access
Semantic Scholar
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus
D. P. Joyce, Jeffrey S. Berger, Allison Guttmann, Ghadeer Hasan +15 more
2024Arthritis Research & Therapy8 citations Open access
Semantic Scholar
Population-based Prevalence and Incidence Estimates of Mixed Connective Tissue Disease from the Manhattan Lupus Surveillance Program
Ghadeer Hasan, E. Ferucci, J. Buyon, H. Belmont +11 more
2022Rheumatology8 citations Open access
Semantic Scholar
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
K. Connelly, R. Koelmeyer, D. Ayton, J. May +48 more
2025Lupus Science and Medicine7 citations Open access
Semantic Scholar
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective
Elena W. Y. Hsieh, James B. Chung, Afsah Amin, A. Askanase +32 more
2025RMD Open7 citations Open access
Semantic Scholar
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
M. Dall'Era, Kenneth C. Kalunian, N. Solomons, M. Truman +3 more
2024Lupus Science and Medicine7 citations Open access
Semantic Scholar
Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence
Jeffrey Kaplan, A. Askanase, David S. Chu, A. Abdellatif +2 more
2023Clinical drug investigation7 citations Open access
Semantic Scholar
Feasibility and Utility of a Pilot Peer Education Program to Improve Patient Engagement in Lupus Clinical Trials: Implementation and Evaluation in a Multisite Model Within a Lupus Clinical Trials Network
S. Sheikh, C. Donovan, C. Menezes, A. Roy +9 more
2023ACR Open Rheumatology7 citations Open access
Semantic Scholar
SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis
Y. Gartshteyn, L. Geraldino-Pardilla, L. Khalili, Shoiab Bukhari +4 more
2024Frontiers in Immunology6 citations Open access
Semantic Scholar
Insights into future management of lupus nephritis
A. Askanase, M. Dall'Era, S. Almaani
2024Frontiers in Lupus6 citations Open access
Semantic Scholar
Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience
J. Lee, A. Mendel, A. Askanase, S. Bae +18 more
2023Annals of the Rheumatic Diseases6 citations
Semantic Scholar
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
A. Askanase, Wei Tang, Q. Zuraw, R. Gordon +2 more
2023Lupus Science and Medicine6 citations Open access
Semantic Scholar
Evaluation of the European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population Based Registry
Allison Guttmann, Brendan Denvir, M. Aringer, Jill P. Buyon +13 more
2022Arthritis care & research6 citations Open access
Semantic Scholar
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Megan R W Barber, M. Ugarte-Gil, J. Hanly, M. Urowitz +34 more
2024Annals of the Rheumatic Diseases5 citations Open access
Semantic Scholar
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE
A. Askanase, C. Aranow, Mimi Y. Kim, D. Kamen +6 more
2023Lupus Science and Medicine5 citations Open access
Semantic Scholar
Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis.
A. Breneman, A. Eber, Hoosna Haque, Libby Levine +11 more
2022Journal of Lower Genital Tract Disease5 citations
Semantic Scholar
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
V. Werth, A. Askanase, I. Lundberg
2021International Journal of Women's Dermatology5 citations Open access
Semantic Scholar
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
M. Mackay, Catriona A. Wagner, A. Pinckney, J. A. Cohen +37 more
2025JCI Insight4 citations Open access
Semantic Scholar
Advanced imaging in the evaluation of lupus arthritis: A systematic literature review and meta-analysis.
Wei Tang, L. Khalili, Ruoyi Gong, M. Souvignier +9 more
2025Seminars in Arthritis & Rheumatism4 citations Open access
Semantic Scholar
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents
A. Askanase, R. Furie, M. Dall'Era, A. Bomback +9 more
2025Rheumatology and Therapy4 citations Open access
Semantic Scholar
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
A. Askanase, R. Furie
2022Advances in Therapy4 citations Open access
Semantic Scholar
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective
Joy Buie, L. Bloch, E. Morand, Ronald F. van Vollenhoven +11 more
2023Lupus Science and Medicine3 citations Open access
Semantic Scholar
SAP expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis
Y. Gartshteyn, L. Geraldino-Pardilla, L. Khalili, Shoiab Bukhari +3 more
2023bioRxiv3 citations Open access
Semantic Scholar
Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
R. Talarico, A. Askanase, M. Cutolo
2023Frontiers in Medicine3 citations Open access
Semantic Scholar
Role of Platelet‐Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus
Y. Gartshteyn, J. Conklin, M. Petri, V. Kyttaris +4 more
2023Arthritis care & research3 citations
Semantic Scholar
Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials
A. Askanase, E. Vital, O. Meier, A. Turchetta +4 more
2025Lupus Science and Medicine2 citations Open access
Semantic Scholar
MACHINE LEARNING CAN IDENTIFY AN ANTINUCLEAR ANTIBODY PATTERN THAT MAY RULE OUT SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES
Farbod Moghaddam, Javad Sajadi, A. Clarke, S. Bernatsky +35 more
2025Journal of Rheumatology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Aranow×13
Invite
C. Aranow — researcher profile on SciRah
M. Dall'Era×12
Invite
M. Dall'Era — researcher profile on SciRah
M. Urowitz×12
Invite
M. Urowitz — researcher profile on SciRah
D. Kamen×11
Invite
D. Kamen — researcher profile on SciRah

R. Ramsey-Goldman

×10

Invite

R. Ramsey-Goldman — researcher profile on SciRah

Invite

J. Hanly — researcher profile on SciRah

S. Bernatsky×9

Invite

S. Bernatsky — researcher profile on SciRah

Invite

E. Ginzler — researcher profile on SciRah

Invite

M. Mackay — researcher profile on SciRah

J. Romero-Díaz×8

Invite

J. Romero-Díaz — researcher profile on SciRah

J. Sánchez-Guerrero×8

Invite

J. Sánchez-Guerrero — researcher profile on SciRah

Invite

D. Gladman — researcher profile on SciRah